https://www.zonebourse.com/cours/action/NGM-BIOPHARMACEUTICALS-IN-56727727/actualite/Ngm-Biopharmaceuticals-Inc-annonce-la-presentation-d-analyses-post-hoc-de-l-essai-de-phase-2-Cata-42203959/?utm_source=telegram&utm_medium=social&utm_campaign=share